VolitionRX VNRX is set to give its latest quarterly earnings report on Thursday, 2024-11-14. Here's what investors need to know before the announcement.
Analysts estimate that VolitionRX will report an earnings per share (EPS) of $-0.07.
Anticipation surrounds VolitionRX's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Past Earnings Performance
During the last quarter, the company reported an EPS beat by $0.01, leading to a 3.19% increase in the share price on the subsequent day.
Here's a look at VolitionRX's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.09 | -0.11 | -0.11 | -0.13 |
| EPS Actual | -0.08 | -0.10 | -0.11 | -0.11 |
| Price Change % | 3.0% | -15.0% | 4.0% | -1.0% |
Performance of VolitionRX Shares
Shares of VolitionRX were trading at $0.748 as of November 12. Over the last 52-week period, shares are down 3.88%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for VolitionRX visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
